Senolytics show promise in combating brain aging and COVID-19 neuropathology

Study reveals that senolytics can reduce aging in human brain organoids and mitigate COVID-19 neuropathology, suggesting their potential as a therapeutic strategy against brain aging and coronavirus-related neurological complications.

Intuitive lands FDA clearance for new da Vinci robot

Listen to the article 3 min This audio is auto-generated. Please let us know if you have feedback. Dive Brief: Intuitive Surgical said Thursday it

March 15, 2024

Opinion | The ‘Best We Have’ Isn’t Working for Endometriosis Patients

Metz is a professor of medical research and the head of a medicinal biochemistry lab. The pain of endometriosis — chronic, severe, and deep —

March 20, 2024

FILAMENT HEALTH ENTERS LICENSING AGREEMENT WITH RESET PHARMA – Psychedelic Alpha

Reset Pharma has licensed Filament’s botanical psilocybin drug candidate for a phase 2 clinical trial studying demoralization syndrome VANCOUVER, BC, Aug. 31, 2023 /CNW/ –

August 31, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.